Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

SELL
$45.44 - $74.26 $4.75 Million - $7.77 Million
-104,623 Reduced 1.33%
7,737,685 $508 Million
Q4 2022

Feb 10, 2023

BUY
$41.39 - $81.0 $81.7 Million - $160 Million
1,973,505 Added 33.63%
7,842,308 $353 Million
Q3 2022

Nov 10, 2022

BUY
$72.36 - $113.1 $46 Million - $71.9 Million
636,031 Added 12.15%
5,868,803 $425 Million
Q2 2022

Aug 12, 2022

BUY
$87.2 - $114.05 $77.4 Million - $101 Million
887,520 Added 20.43%
5,232,772 $561 Million
Q1 2022

May 13, 2022

BUY
$94.19 - $124.49 $83.6 Million - $110 Million
887,274 Added 25.66%
4,345,252 $482 Million
Q4 2021

Feb 11, 2022

SELL
$119.57 - $139.07 $3.89 Million - $4.53 Million
-32,575 Reduced 0.93%
3,457,978 $443 Million
Q3 2021

Nov 12, 2021

SELL
$109.17 - $142.35 $18.3 Million - $23.9 Million
-167,643 Reduced 4.58%
3,490,553 $464 Million
Q2 2021

Aug 12, 2021

SELL
$100.34 - $115.69 $13.1 Million - $15.1 Million
-130,753 Reduced 3.45%
3,658,196 $396 Million
Q1 2021

May 11, 2021

SELL
$101.51 - $125.27 $49.2 Million - $60.8 Million
-485,066 Reduced 11.35%
3,788,949 $399 Million
Q4 2020

Feb 10, 2021

SELL
$85.88 - $105.36 $17.2 Million - $21.1 Million
-199,929 Reduced 4.47%
4,274,015 $445 Million
Q3 2020

Nov 12, 2020

SELL
$72.74 - $92.5 $271,683 - $345,487
-3,735 Reduced 0.08%
4,473,944 $383 Million
Q2 2020

Aug 12, 2020

BUY
$48.02 - $79.04 $25 Million - $41.1 Million
519,911 Added 13.14%
4,477,679 $328 Million
Q1 2020

May 12, 2020

BUY
$36.95 - $62.95 $58.5 Million - $99.7 Million
1,583,582 Added 66.7%
3,957,768 $206 Million
Q4 2019

Feb 12, 2020

BUY
$47.06 - $56.64 $25.3 Million - $30.5 Million
538,251 Added 29.32%
2,374,186 $134 Million
Q3 2019

Nov 12, 2019

BUY
$47.45 - $58.05 $41.9 Million - $51.3 Million
883,518 Added 92.77%
1,835,935 $87.5 Million
Q2 2019

Aug 09, 2019

BUY
$39.26 - $54.21 $37.4 Million - $51.6 Million
952,417 New
952,417 $51.6 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Artisan Partners Limited Partnership Portfolio

Follow Artisan Partners Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artisan Partners Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Artisan Partners Limited Partnership with notifications on news.